famotidine has been researched along with Diabetes Mellitus in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varughese, GI | 1 |
| Scarpello, JH | 1 |
| Schwetz, BA | 1 |
2 other studies available for famotidine and Diabetes Mellitus
| Article | Year |
|---|---|
Metformin and vitamin B12 deficiency: the role of H2 receptor antagonists and proton pump inhibitors.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Famotidine; Gastritis; Histamine H2 Antagonists; Humans; | 2007 |
From the Food and Drug Administration.
Topics: Anti-Ulcer Agents; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus; Drug Labeling; F | 2001 |